Want to see TSE:GLOW full AI Analyst Report?
GLOW Stock Chart & Stats
C$0.06
>-C$0.01(-7.69%)
At close: 4:00 PM EST
C$0.06
>-C$0.01(-7.69%)
Day’s Range― - ―
52-Week RangeC$0.04 - C$0.08
Previous CloseN/A
Volume6.00K
Average Volume (3M)266.05K
Market Cap
C$8.66M
Enterprise ValueC$7.11M
Total Cash (Recent Filing)C$1.59M
Total Debt (Recent Filing)C$45.48K
Price to Earnings (P/E)―
Beta0.18
Next Earnings
Sep 01, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)<0.01
Shares Outstanding192,435,550
10 Day Avg. Volume165,602
30 Day Avg. Volume266,047
Financial Highlights & Ratios
PEG Ratio0.19
Price to Book (P/B)3.82
Price to Sales (P/S)5.04
P/FCF Ratio-87.53
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Strong Revenue GrowthVery high revenue growth (TTM revenue up meaningfully) indicates strong demand and traction for the company’s offerings. Sustained top-line expansion supports scale economics, increases optionality for partnerships and funding, and provides a foundation to absorb costs and progress toward profitability over months.
Low Financial LeverageVery small debt relative to equity gives the company financial flexibility and reduces default risk during a burn phase. Low leverage preserves capacity to raise debt if needed, lowers fixed financing costs, and improves resilience while management works to convert growth into positive cash flow.
Material Improvement In Free Cash Flow And LossesImproving free cash flow and narrower losses show progress in cost structure and operational execution. This trend, if maintained, will reduce external funding needs, extend runway, and increase the likelihood of achieving sustainable operating cash flow within a multi-month horizon.
Bears Say
Ongoing Negative Operating Cash FlowPersistently negative operating cash flow means the business still consumes cash to run operations, forcing reliance on external financing or reserves. That elevates dilution and refinancing risk, constrains reinvestment, and limits the company’s strategic flexibility until cash generation turns sustainably positive.
Sustained Unprofitability And Weak MarginsNegative operating profit, negative EBITDA and a roughly -30% net margin indicate the business has not proven a path to breakeven. Continued unprofitability increases the chance of recurring cash deficits, makes scaling riskier, and challenges long-term return on invested capital absent structural margin improvement.
Balance-sheet Volatility And Prior Negative EquityA prior year of negative equity and balance-sheet swings signal past solvency pressure and financial fragility. This history can raise lender and partner caution, increase cost of capital, and amplify dilution risk if further capital raises are required to cover continued operational losses.
Glow LifeTech News
GLOW FAQ
What was Glow LifeTech’s price range in the past 12 months?
Glow LifeTech lowest stock price was C$0.04 and its highest was C$0.07 in the past 12 months.
What is Glow LifeTech’s market cap?
Glow LifeTech’s market cap is C$8.66M.
When is Glow LifeTech’s upcoming earnings report date?
Glow LifeTech’s upcoming earnings report date is Sep 01, 2026 which is in 61 days.
How were Glow LifeTech’s earnings last quarter?
Currently, no data Available
Is Glow LifeTech overvalued?
According to Wall Street analysts Glow LifeTech’s price is currently Overvalued.
Does Glow LifeTech pay dividends?
Glow LifeTech does not currently pay dividends.
What is Glow LifeTech’s EPS estimate?
Glow LifeTech’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Glow LifeTech have?
Glow LifeTech has 192,435,550 shares outstanding.
What happened to Glow LifeTech’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Glow LifeTech?
Currently, no hedge funds are holding shares in TSE:GLOW
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Glow LifeTech
Glow Lifetech Corp. is a biotechnology enterprise based in North America, dedicated to the development and marketing of nutraceutical and cannabinoid-derived products. The company is actively commercializing two core technologies: MyCell Enhanced technology, which facilitates the optimal delivery of nutrients for both nutraceuticals and cannabis, and a Cannabis Smart Consumption System, designed to help users and patients store, track, manage, and consume cannabis products effectively. Glow Lifetech possesses exclusive rights throughout North America for the production, sale, and distribution of a specific micellization technology, applicable to cannabis and hemp-derived ingredients, curcumin, Vitamin K, and iron. A key aspect of their operations involves the advanced processing of ingredients, converting certain vitamins, nutraceuticals, and cannabis extracts into micellized forms. This process significantly boosts the bioavailability of fat-soluble compounds, ensuring near 100% absorption into the body and enhancing their compatibility with water. The company, founded in 2018, is headquartered in Toronto, Canada.
Technical Analysis
COSCIENS Biopharma
―
Kane Biotech
―
Quest Pharmatech
―
PreveCeutical Medical
―
PharmAla Biotech Holdings, Inc.
―
Options Prices
Currently, No data available
---